INSIGHTS ON CLINICAL TRIAL DESIGN
-
Ensuring Compliance In Gene Therapy Trials: IRB And IBC Views
Explore ethical and regulatory challenges in neurological gene therapy trials, with expert insights on IRB/IBC collaboration, consent protocols, and oversight for vulnerable populations.
-
Bridging The Trust Gap: How Patient Advocacy Groups Transforms Trial Recruitment
Explore how collaboration between researchers and Patient Advocacy Groups (PAGs) can bridge the trust gap that undermines recruitment and can make trial participation more approachable and meaningful.
-
IRB In Action: A Live Mock Board Review
Experience a live mock IRB review! Watch industry experts evaluate a fictional protocol to uncover insights into board decision-making, master the review process, and improve your future submissions.
-
Illuminating IHC: From Biomarker To Clinical Trial Assay
Through this presentation, Immunohistochemistry (IHC) expert equip you with the knowledge needed to effectively utilize IHC in your research and clinical practice.
-
Site Networks And Hybrid Solutions7/22/2025
Learn how community- and patient-centric site networks that have DCT capabilities are able to work with a broad-range of site types.
-
Has Your Clinical Trial Outgrown Its RTSM Software? Here's What to Watch For3/25/2026
This clip explores how rigid RTSM systems push teams into risky manual workarounds and highlights why flexible, adaptable technology is essential when studies evolve and operational demands shift.
-
Why Specialty Lab Samples Are So Vulnerable To Trial Execution Errors7/17/2026
Biomarkers and other specialty lab samples are among the most fragile parts of clinical trial execution, but what makes them so vulnerable to mishandling, and what are the effects?
-
Living With An Invisible Disease: One Woman's Journey With CF4/22/2025
Meet a clinical research participant who has spent her life navigating the challenges of cystic fibrosis, leading her to become an advocate, amplifying the voices of others facing similar struggles.
-
Operationalizing Immuno-Oncology Studies5/29/2026
Managing CRS and immune risks demands early detection, rapid response, and skilled teams. Strong infrastructure and clear protocols enable safer immunotherapy trials beyond academic centers.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Looking to better understand how to solve your organization’s specific clinical trial challenges? In 3 minutes, receive a personalized assessment, with customized results based on a specific role, which will provide a solution-based report curated to your priorities and requirements.
-
Psychiatric trials have long been among the most difficult to enroll. From treatment-resistant depression (TRD) and PTSD to cognitive and neuro disorders, sponsors are facing the same challenges over and over again:
- Narrow I/E criteria that don’t translate into real-world patients
- Sites with limited behavioral health infrastructure
- Lack of patient trust and trial awareness in psychiatric populations
- Professional patients
- Rating scales aren’t used in clinical practices
But what if recruitment didn’t have to start with a gamble?
-
Whether you need isotopically labelled (14C/SIL) compounds for nonclinical or clinical metabolism studies and the quantification of materials in biological matrices, our expertise provides the necessary labelled materials tailored to support your studies.
-
Through Home Trial Support (HTS), it is possible to carry out even the most demanding sampling protocols safely, consistently, and at scale—bringing collection and processing directly to patients.
-
Dedicated Patient Liaison support helps coordinate participant travel, reimbursements, and visit logistics so sites stay focused and study requests keep moving forward.